3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Radiodermatitis
2
Neoplasms
2
Multiple Myeloma
2
Adenomatous Polyposis Coli
2
Stomach Neoplasms
1
Smoldering Multiple Myeloma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Mucositis
1
Monoclonal Gammopathy of Undetermined Significance
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Gastritis, Atrophic
1
Fatigue
1
Communicable Diseases
1
Breast Carcinoma In Situ
1
Adenocarcinoma
1
Interventions
Leucovorin
38
Fluorouracil
36
Oxaliplatin
34
Bevacizumab
34
Irinotecan
32
Cetuximab
23
Capecitabine
18
Panitumumab
14
IFL protocol
7
Folfox protocol
6
Celecoxib
6
Radiotherapy
5
Nivolumab
5
Magnetic Resonance Spectroscopy
5
Immunohistochemistry
5
Gene Expression Profiling
5
regorafenib
4
pembrolizumab
4
dehydroftorafur
4
Ramucirumab
4
Fluorodeoxyglucose F18
4
Floxuridine
4
aflibercept
3
Surgical Procedures, Operative
3
Sorafenib
3
Radiosurgery
3
Ipilimumab
3
Gemcitabine
3
Fentanyl
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Colonic Neoplasms
×
Curcumin
×
Clear all
No trials found.